Tested Applications
| Positive IHC detected in | mouse liver tissue, human liver cancer tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
Recommended dilution
| Application | Dilution |
|---|---|
| Immunohistochemistry (IHC) | IHC : 1:300-1:1200 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
20214-1-AP targets IGF1A-Specific in WB, IHC, IF, ELISA applications and shows reactivity with human, mouse samples.
| Tested Reactivity | human, mouse |
| Cited Reactivity | human, mouse, rat, pig |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
Peptide Predict reactive species |
| Full Name | insulin-like growth factor 1 (somatomedin C) |
| Calculated Molecular Weight | 17 kDa |
| Gene Symbol | IGF1 |
| Gene ID (NCBI) | 3479 |
| RRID | AB_10666736 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | P05019 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
IGF1, also named as IBP1, MGF, IGF-IA and Somatomedin-C, belongs to the INS family. IGF1 is structurally and functionally related to INS but have a much higher growth-promoting activity. Altered expression or mutation of IGF-1 is associated with several human disorders, including type I diabetes and various forms of cancer. Defects in IGF1 are the cause of INS-like growth factor I deficiency (IGF1 deficiency) which is an autosomal recessive disorder characterized by growth retardation, sensorineural deafness and mental retardation. The antibody is specific to isoform IGF-1A.
Protocols
| Product Specific Protocols | |
|---|---|
| IHC protocol for IGF1A-Specific antibody 20214-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The IGF1A-Specific Polyclonal antibody (Cat# 20214-1-AP) has 21 citations. These appear in journals including Journal of Hepatology, Gastroenterology, Cancer Letters, PNAS, Science China Life Sciences, Frontiers in Endocrinology, Cancer Biology & Therapy, Molecular Neurobiology, Obesity, International Journal of Cancer, Brain Research Bulletin, FEBS Journal, Angle Orthodontist, Journal of Applied Physiology, Histochemistry and Cell Biology, Journal of Pharmacological Sciences, PLoS One, International Journal of Legal Medicine, Neuroscience Letters, and Journal of Addictive Prevention. Research fields span hepatology, oncology (liver, colorectal, lung, glioma, pancreatic), obesity/metabolism, neurodegeneration (ALS), diabetes, muscle injury/regeneration, orthodontics, and osteoarthritis.
| Species | Application | Title |
|---|---|---|
J Hepatol Deficiency of insulin-like growth factor 1 attenuates aging-induced changes in hepatic function: Role of autophagy. | ||
Gastroenterology Regulator of Calcineurin 1 Gene Isoform 4, Downregulated in Hepatocellular Carcinoma, Prevents Proliferation, Migration, and Invasive Activity of Cancer Cells and Growth of Orthotopic Tumors by Inhibiting Nuclear Translocation of NFAT1. | ||
Cancer Lett IFN-γ-mediated IRF1/miR-29b feedback loop suppresses colorectal cancer cell growth and metastasis by repressing IGF1. | ||
Sci China Life Sci Targeting IGF1 to alleviate obesity through regulating energy expenditure and fat deposition | ||
Proc Natl Acad Sci U S A Disruption of the AMPK-TBC1D1 nexus increases lipogenic gene expression and causes obesity in mice via promoting IGF1 secretion. | ||







